3x founder

Jeff Liu

The Dude @ FinalDose, YC (P26) | Co-founder & CTO @ Vivid Dx

Co-founder

FinalDose· Spring 2026🇬🇧 United Kingdom

in LinkedIn

2026The Dude· FinalDose

Founder · since 2019

Company

FinalDose

Role

The Dude

current

Stage

—

no public source

Raised

—

no public source

Based

—

Founder / co-founder — the company's markEmployee / research role

Source: LinkedIn work history

Profile coverage5 of 7 · missing posts, contact

FinalDose

Programmable DNA drug destroying all cancers, unlocking 80% of targets

Spring 2026

Experience

Career

FinalDose
The Dude · 2026 – Present
2026
Vivid Dx
Co-founder
Co-Founder & CTO · Oxford · 2022 – Present
2022
Oxford MEStar Ltd
Bioinformatics Consultant · Oxford, England, United Kingdom · 2021 – 2022
2021
Stemblue
Founder
Founder, CEO · Oxford, England, United Kingdom · 2020 – 2022
2020
MRC Weatherall Institute of Molecular Medicine
PHD Researcher · Oxford, England, United Kingdom · 2017 – 2021
2017
University of Oxford
Doctoral Researcher · Oxford · 2017 – 2021
2017
Humango
Founder
Founder, CEO · Oxford, England, United Kingdom · 2019 – 2020
2019
USC Eli and Edythe Broad Center, Andrew P. McMahon Lab
Research Associate · California, United States · 2015 – 2016
2015
USC Zilkha Neurogenetic Institute, Robert Chow Lab
Research Assistant · California, United States · 2014 – 2015
2014
National Taipei University of Technology
Research Assistant · Taipei City, Taiwan · 2014
2014
Keck Medicine of USC
Research Assistant · California, United States · 2013
2013
AHBLab
Research Associate · Taipei City, Taiwan · 2013
2013
Caltech
Research Assistant · California, United States · 2011 – 2012
2011

Bio

CEO @ FinalDose (YC P26). Oxford PhD in Oncology. Previous startup (Vivid Dx) solved a multi-decade bottleneck in sepsis diagnostics: low biomass isolation. By overcoming this hurdle, we built the world’s fastest diagnostic system - slashing wait times from 5 days to just 30 minutes. Raised $15M in venture backing.